Using the same murine KP2 PDAC tumor model, we observed that IAPinh and S2/IAPinh treated tumors showed significant decreases in cIAP-1 protein levels when compared with controls and are in accordance with the results of our in vitro drug characterization efforts described above (Fig. 6C and D). This evidence concerns the gene BIRC2 and neoplasm.